Randomised clinical trial: the clinical efficacy and safety of an alginate‐antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|42|7|845-854

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.7, 2015-10, pp. : 845-854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomised clinical trial: sodium alginate oral suspension is non‐inferior to omeprazole in the treatment of patients with non‐erosive gastroesophageal disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 9, 2013-11 ,pp. : 1054-1064

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical relevance of esophageal and gastric pH measurements in patients with gastro-esophageal reflux disease (GERD)

By DiMarino Anthony J.   Cohen Sidney  

Current Medical Research and Opinion, Vol. 21, Iss. 1, 2005-01 ,pp. : 27-36

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial – an Indian experience

By Kumar Das Siddharth   Pareek Anil   Mathur D. S.   Wanchu Ajay   Srivastava Ragini   Agarwal G. G.   Chauhan R. S.  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2227-2234

Informa Healthcare

Access to resources Recommend Favorite

Tolvaptan in hospitalized cancer patients with hyponatremia: A double‐blind, randomized, placebo‐controlled clinical trial on efficacy and safety

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 744-751

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised clinical trial: the 5‐HT4 agonist revexepride in patients with gastro‐oesophageal reflux disease who have persistent symptoms despite PPI therapy

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 649-661

John Wiley & Sons Inc

Access to resources Recommend Favorite